TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotech Fluidics AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
73,666
|
106,508
|
101,205 |
| Financial expenses |
68
|
0
|
1 |
| Earnings before taxes |
7,320
|
12,184
|
14,637 |
| EBITDA |
5,649
|
11,040
|
13,622 |
| Total assets |
45,583
|
47,637
|
45,902 |
| Current assets |
35,896
|
39,838
|
41,128 |
| Current liabilities |
7,110
|
11,141
|
15,723 |
| Equity capital |
36,169
|
34,359
|
28,612 |
| - share capital |
101
|
101
|
101 |
| Employees (average) |
14
|
13
|
13 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
79.3%
|
72.1%
|
62.3% |
| Turnover per employee |
5,262
|
8,193
|
7,785 |
| Profit as a percentage of turnover |
9.9%
|
11.4%
|
14.5% |
| Return on assets (ROA) |
16.2%
|
25.6%
|
31.9% |
| Current ratio |
504.9%
|
357.6%
|
261.6% |
| Return on equity (ROE) |
20.2%
|
35.5%
|
51.2% |
| Change turnover |
-32,842
|
5,303
|
30,830 |
| Change turnover % |
-31%
|
5%
|
44% |
| Chg. No. of employees |
1
|
0
|
1 |
| Chg. No. of employees % |
8%
|
0%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.